[go: up one dir, main page]

ZA200207675B - Novel crystal form of pyrrolidylthiocarbapenem derivative. - Google Patents

Novel crystal form of pyrrolidylthiocarbapenem derivative.

Info

Publication number
ZA200207675B
ZA200207675B ZA200207675A ZA200207675A ZA200207675B ZA 200207675 B ZA200207675 B ZA 200207675B ZA 200207675 A ZA200207675 A ZA 200207675A ZA 200207675 A ZA200207675 A ZA 200207675A ZA 200207675 B ZA200207675 B ZA 200207675B
Authority
ZA
South Africa
Prior art keywords
novel crystal
crystal form
pyrrolidylthiocarbapenem derivative
pyrrolidylthiocarbapenem
derivative
Prior art date
Application number
ZA200207675A
Other languages
English (en)
Inventor
Izumi Saitoh
Masayuki Takahira
Toshio Kawakita
Yasuyuki Yoshioka
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18614158&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200207675(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of ZA200207675B publication Critical patent/ZA200207675B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
ZA200207675A 2000-03-31 2002-09-25 Novel crystal form of pyrrolidylthiocarbapenem derivative. ZA200207675B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000099868 2000-03-31

Publications (1)

Publication Number Publication Date
ZA200207675B true ZA200207675B (en) 2003-09-25

Family

ID=18614158

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200207675A ZA200207675B (en) 2000-03-31 2002-09-25 Novel crystal form of pyrrolidylthiocarbapenem derivative.

Country Status (17)

Country Link
US (5) US20030153191A1 (ja)
EP (1) EP1270575B1 (ja)
JP (1) JP3375084B2 (ja)
KR (1) KR100472842B1 (ja)
CN (1) CN1192030C (ja)
AT (1) ATE304014T1 (ja)
AU (2) AU2001244692B2 (ja)
BR (1) BRPI0109712B8 (ja)
CA (1) CA2404703C (ja)
CY (2) CY1105674T1 (ja)
DE (1) DE60113243T2 (ja)
DK (1) DK1270575T3 (ja)
ES (1) ES2252205T3 (ja)
MX (1) MXPA02009592A (ja)
TW (1) TWI293631B (ja)
WO (1) WO2001072750A1 (ja)
ZA (1) ZA200207675B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60113243T2 (de) * 2000-03-31 2006-02-16 Shionogi & Co., Ltd. Neue kristalline form eines pyrrolidylthiocarbapenem-derivates
JP5004355B2 (ja) * 2001-05-10 2012-08-22 塩野義製薬株式会社 アセチルチオピロリジン誘導体の製法
BR0214209A (pt) * 2001-11-16 2004-10-26 Ranbaxy Lab Ltd Processo para a preparação de imipenem cristalino e composto preparado pelo dito processo
TWI353855B (en) 2005-05-26 2011-12-11 Shionogi & Co Method for preparing an aqueous solution of doripe
US8093378B2 (en) * 2006-04-28 2012-01-10 Kaneka Corporation Crystallization method for intermediates of carbapenem antibiotics
CN101466713A (zh) * 2006-07-03 2009-06-24 成都地奥九泓制药厂 多尼培南的新结晶及其制备方法和用途
CN101191787B (zh) * 2006-11-21 2011-07-27 上海医药工业研究院 高效液相色谱法测定多利培南含量的方法
WO2009118680A1 (en) 2008-03-24 2009-10-01 Ranbaxy Laboratories Limited Process for the preparation of sterile doripenem
CN103025733B (zh) * 2010-06-03 2015-11-25 山东轩竹医药科技有限公司 碳青霉烯类衍生物或其水合物的晶型及其制备方法与用途
CN102977101A (zh) * 2011-09-07 2013-03-20 中国人民解放军军事医学科学院毒物药物研究所 多尼培南一水合物、其药物组合物、其制备方法和用途
CN102285988B (zh) * 2011-09-08 2012-09-05 上海希迈医药科技有限公司 一种多尼培南水合物晶体及其制备方法
US20150291591A1 (en) * 2011-11-08 2015-10-15 Ranbaxy Laboratories Limited Process for the preparation of polymorphs of doripenem
CN104072497B (zh) * 2013-03-29 2017-10-03 石药集团中奇制药技术（石家庄）有限公司 一种多尼培南新结晶及其制备方法
CN103389347B (zh) * 2013-07-26 2015-12-09 深圳市海滨制药有限公司 高效液相色谱法测定多尼培南的方法
KR101910048B1 (ko) 2014-04-28 2018-10-22 제이더블유중외제약 주식회사 도리페넴의 신규한 결정 및 이의 제조방법
KR20160007679A (ko) 2016-01-04 2016-01-20 제일약품주식회사 도리페넴의 신규한 결정형

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
US5539102A (en) * 1992-02-21 1996-07-23 Shionogi Seiyaku Kabushiki Kaisha Production method for sulfamide
DE69528166T2 (de) * 1994-05-02 2003-04-30 Shionogi & Co., Ltd. Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung
JP3558684B2 (ja) * 1994-06-28 2004-08-25 塩野義製薬株式会社 ピロリジルチオカルバペネム誘導体の乾燥方法
DE60113243T2 (de) * 2000-03-31 2006-02-16 Shionogi & Co., Ltd. Neue kristalline form eines pyrrolidylthiocarbapenem-derivates
EP1595883A4 (en) * 2003-02-14 2008-11-26 Shionogi & Co INTERMEDIATE PRODUCT CRYSTAL FOR CARBAPENEM
WO2010097686A1 (en) 2009-02-26 2010-09-02 Orchid Chemicals & Pharmaceuticals Ltd An improved process for the preparation of carbapenem antibiotic

Also Published As

Publication number Publication date
BRPI0109712B8 (pt) 2021-05-25
EP1270575B1 (en) 2005-09-07
EP1270575A4 (en) 2004-02-18
WO2001072750A1 (fr) 2001-10-04
CY2009001I1 (el) 2009-11-04
CA2404703A1 (en) 2002-09-26
ES2252205T3 (es) 2006-05-16
CA2404703C (en) 2007-06-05
CY2009001I2 (el) 2009-11-04
US20130059831A1 (en) 2013-03-07
JP3375084B2 (ja) 2003-02-10
AU4469201A (en) 2001-10-08
CN1192030C (zh) 2005-03-09
BR0109712A (pt) 2003-04-29
ATE304014T1 (de) 2005-09-15
BRPI0109712B1 (pt) 2017-10-24
US20150031664A1 (en) 2015-01-29
US9221823B2 (en) 2015-12-29
KR20020087446A (ko) 2002-11-22
TWI293631B (ja) 2008-02-21
US20080207586A1 (en) 2008-08-28
US8247402B2 (en) 2012-08-21
EP1270575A1 (en) 2003-01-02
DK1270575T3 (da) 2006-01-16
US20030153191A1 (en) 2003-08-14
US20070060562A1 (en) 2007-03-15
DE60113243D1 (de) 2005-10-13
DE60113243T2 (de) 2006-02-16
AU2001244692B2 (en) 2004-10-14
CY1105674T1 (el) 2010-07-28
MXPA02009592A (es) 2003-03-12
KR100472842B1 (ko) 2005-03-10
CN1432016A (zh) 2003-07-23

Similar Documents

Publication Publication Date Title
ZA200207675B (en) Novel crystal form of pyrrolidylthiocarbapenem derivative.
IL157773A0 (en) 2-amino-propanol derivatives
AP2002002637A0 (en) Novel piperazine
CA2368347A1 (en) Glucokinase activators
CA2445306A1 (en) Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
CA2150123A1 (en) Aminomethylene substituted non-aromatic heterocycles
EP1783113A3 (en) Crystal form VII of atorvastatin hemi-calcium
MA23257A1 (fr) Nouvelle forme de compose demagnesium d'omeprazole etson utilisation .
AU2003297291A1 (en) Substituted arylcyclopropylacetamides as glucokinase activators
AU2003278592A1 (en) A novel crystalline form of linezolid
AU673893B2 (en) New pyridothiadiazones, processes for their preparation and the pharmaceutical compositions which contain them
CA2043709A1 (en) Antimigraine alkoxypyrimidine derivatives
IL123078A0 (en) Pharmaceutical compositions containing carbapenem and their preparation
CA2505968A1 (en) Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
HK72592A (en) Substituted benzamide
DE60311516D1 (en) Perindopril
CA2125549A1 (en) Tetrazole derivatives, their production and use
GR3033350T3 (en) Use of Beta-aminopropionic acid derivatives as fungicides
AU5028393A (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents
CA2155323A1 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
CA2411787A1 (en) Stable gabapentin having ph within a controlled range
AU2002245005A1 (en) Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor
CA2427762A1 (en) Process for the preparation of crystalline n-formimidoyl thienamycin monohydrate (imipenem monohydrate)
CA2127374A1 (fr) Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent
CA2217855A1 (en) Tetralines